FGD5-AS1/miR-106b-5p/FDX1 axis governs cuproptosis to affect clear cell renal cell carcinoma progression via metabolic-immune crosstalk.
- DOI
- 10.1007/s12032-026-03495-0
- Published
- 2026 Nov 10
- Container
- Medical oncology (Northwood, London, England)
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s12032-026-03495-0,
title = {FGD5-AS1/miR-106b-5p/FDX1 axis governs cuproptosis to affect clear cell renal cell carcinoma progression via metabolic-immune crosstalk.},
author = {Tang F and Wang W and Chang Y and Gu Y and Wei X and Ren Y and Ouyang Y and Zhang S},
year = {2026},
journal = {Medical oncology (Northwood, London, England)},
doi = {10.1007/s12032-026-03495-0},
url = {https://doi.org/10.1007/s12032-026-03495-0}
}RIS
TY - JOUR TI - FGD5-AS1/miR-106b-5p/FDX1 axis governs cuproptosis to affect clear cell renal cell carcinoma progression via metabolic-immune crosstalk. AU - Tang F AU - Wang W AU - Chang Y AU - Gu Y AU - Wei X AU - Ren Y AU - Ouyang Y AU - Zhang S PY - 2026 JO - Medical oncology (Northwood, London, England) DO - 10.1007/s12032-026-03495-0 UR - https://doi.org/10.1007/s12032-026-03495-0 ER -
APA
F, T., W, W., Y, C., Y, G., X, W., Y, R., Y, O., & S, Z. (2026). FGD5-AS1/miR-106b-5p/FDX1 axis governs cuproptosis to affect clear cell renal cell carcinoma progression via metabolic-immune crosstalk.. Medical oncology (Northwood, London, England). https://doi.org/10.1007/s12032-026-03495-0
Source records
- pubmed · retrieved 2026-11-11T04:38:01.219Z